Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes

Research output: Contribution to journal › Editorial

9 Citations (Scopus)

Original language	English
Pages (from-to)	62-66
Number of pages	5
Journal	Therapeutic Advances in Drug Safety
Volume	5
Issue number	2
DOIs	https://doi.org/10.1177/2042098613520030
Publication status	Published - Apr 2014

Access to Document

@article{de02b61bafea47979e5e8ac5d2e8aec2,

title = "Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes",

author = "Michael Sorich and Andrew Rowland and Michael Wiese",

year = "2014",

month = apr,

doi = "10.1177/2042098613520030",

language = "English",

volume = "5",

pages = "62--66",

journal = "Therapeutic Advances in Drug Safety",

issn = "2042-0986",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes

AU - Sorich, Michael

AU - Rowland, Andrew

AU - Wiese, Michael

PY - 2014/4

Y1 - 2014/4

UR - http://www.scopus.com/inward/record.url?scp=84898989310&partnerID=8YFLogxK

U2 - 10.1177/2042098613520030

DO - 10.1177/2042098613520030

M3 - Editorial

SN - 2042-0986

VL - 5

SP - 62

EP - 66

JO - Therapeutic Advances in Drug Safety

JF - Therapeutic Advances in Drug Safety

IS - 2

ER -